matejmo/iStock via Getty Images By Elior Manier General sentiment has not worsened following President Trump's attempts on Monday morning to ease concerns surrounding the current narrative. As the conflict extends into its fifth week, skepticism grows regarding the initial deadline given for how long the operation would last. Investors are increasingly worried about the possibility that the situat...
matejmo/iStock via Getty Images By Elior Manier General sentiment has not worsened following President Trump's attempts on Monday morning to ease concerns surrounding the current narrative. As the conflict extends into its fifth week, skepticism grows regarding the initial deadline given for how long the operation would last. Investors are increasingly worried about the possibility that the situation may deteriorate further before it improves. Over the weekend, the Pentagon announced preparations for a limited ground operation to conclude the ongoing war. This announcement evoked comparisons to the conflicts in Afghanistan and Iraq, though the President's morning message on Truth Social helped alleviate some anxiety. (Donald Trump's Morning Truth Social Post, March 30, 2026.) Fed Chair Jerome Powell just delivered a speech at a conference at Harvard , reiterating that the Federal Reserve is well-equipped to handle current challenges. He provided further insights into the impact of tariffs and expressed an optimistic outlook on the economy, which contributed to the ongoing extension higher in stock markets. One of the better comments for investors came from the fact that the Fed Chair did not deem that private credit stress would contaminate other parts of the financial system, a source of general concern in recent weeks. Despite a rebound in WTI crude prices above the symbolic $100 mark, along with a similar increase in the US dollar, market participants appear to be looking ahead. All US benchmarks are rallying, with yields also easing across the board. These upward movements will be welcomed after last week's troubling market activity. However, stocks are not entirely out of trouble yet, and there is still a significant chance that this upward movement may just be a temporary retracement, especially in the absence of a long-term solution. To gauge today’s market direction, let’s examine the intraday charts and trading levels for the major US indexes: the Dow Jones...
Americans are increasingly turning against artificial intelligence, with growing majorities saying they fear the fast-moving technology will take away their jobs and hurt education, according to a new Quinnipiac poll . Fifty-five percent of Americans say AI will do more harm than good in their day-to-day lives, an 11% increase since last April, according to poll results released Monday. Americans’...
Americans are increasingly turning against artificial intelligence, with growing majorities saying they fear the fast-moving technology will take away their jobs and hurt education, according to a new Quinnipiac poll . Fifty-five percent of Americans say AI will do more harm than good in their day-to-day lives, an 11% increase since last April, according to poll results released Monday. Americans’ worries are worsening as companies channel huge sums into deploying the technology, which has become an engine for US economic growth. Together, Amazon.com Inc. , Meta Platforms Inc. , Google and Microsoft Corp. plan to spend a combined $650 billion this year on AI infrastructure. AI billionaires such as venture capitalist Marc Andreessen and OpenAI President Greg Brockman have poured tens of millions of dollars into the upcoming US midterm elections to elect AI-friendly candidates and lobby for light-touch regulation. Data center construction has emerged as one of the most potent AI-related battles in the upcoming midterm elections, following outcries in communities across the country. Sixty-five percent of Americans oppose the building of any AI data centers in their community. The impact on electricity costs, water use and noise were the main reasons cited by poll respondents. The Quinnipiac poll tracks with other surveys that show Americans are increasingly concerned about AI-related job loss and misinformation. One poll from NBC News showed voters like AI even less than Immigration and Customs Enforcement. Public fears mirror warnings sounded by some prominent figures within the AI industry. Anthropic CEO Dario Amodei earlier this year cautioned that AI will trigger an “unusually painful” disruption in the job market. Seventy percent of Americans think advancements in AI are likely to reduce job opportunities, 14% more than said so last year. Only 7% said they think advancements in AI are likely to increase job opportunities. A slight majority of Americans said they o...
(Bloomberg) -- Americans are increasingly turning against artificial intelligence, with growing majorities saying they fear the fast-moving technology will take away their jobs and hurt education, according to a new Quinnipiac poll.Fifty-five percent of Americans say AI will do more harm than good in their day-to-day lives, an 11% increase since last April, according to poll results released Monda...
(Bloomberg) -- Americans are increasingly turning against artificial intelligence, with growing majorities saying they fear the fast-moving technology will take away their jobs and hurt education, according to a new Quinnipiac poll.Fifty-five percent of Americans say AI will do more harm than good in their day-to-day lives, an 11% increase since last April, according to poll results released Monday. Americans’ worries are worsening as companies channel huge sums into deploying the technology, wh
Intel (NASDAQ:INTC) shares are sliding 5% in Monday trading, pulling back to the $41 area. Advanced Micro Devices (NASDAQ:AMD) is also in the red, falling 3% to $196 and change. The pullback carries a sharp irony. Both stocks surged last Wednesday, March 25, after reports emerged that Intel and AMD plan to raise CPU prices ... Intel Slides 5%, AMD Drops 3%: The Semiconductor Sector Is at a Crossro...
Intel (NASDAQ:INTC) shares are sliding 5% in Monday trading, pulling back to the $41 area. Advanced Micro Devices (NASDAQ:AMD) is also in the red, falling 3% to $196 and change. The pullback carries a sharp irony. Both stocks surged last Wednesday, March 25, after reports emerged that Intel and AMD plan to raise CPU prices ... Intel Slides 5%, AMD Drops 3%: The Semiconductor Sector Is at a Crossroads
Over the last 7 days, the United States market has dropped 1.9%, yet it remains up by 15% over the past year with earnings forecasted to grow by 15% annually, indicating a resilient and optimistic outlook for investors. In this context, identifying high growth tech stocks involves assessing companies that not only capitalize on technological advancements but also demonstrate strong potential for s...
Over the last 7 days, the United States market has dropped 1.9%, yet it remains up by 15% over the past year with earnings forecasted to grow by 15% annually, indicating a resilient and optimistic outlook for investors. In this context, identifying high growth tech stocks involves assessing companies that not only capitalize on technological advancements but also demonstrate strong potential for sustained revenue and earnings growth in line with or exceeding these market trends.
Every color of the Beats Powerbeats Fit are discounted. | Image: Apple For iPhone owners, the AirPods Pro 3 are a fantastic all-around set of wireless earbuds, even for working out. Their value is especially tough to beat at $199.99 ; however, even with five sizes of silicone tips, they aren’t the best fit for some people, or for some kinds of workouts. If earbuds tend to fall out of your ears, th...
Every color of the Beats Powerbeats Fit are discounted. | Image: Apple For iPhone owners, the AirPods Pro 3 are a fantastic all-around set of wireless earbuds, even for working out. Their value is especially tough to beat at $199.99 ; however, even with five sizes of silicone tips, they aren’t the best fit for some people, or for some kinds of workouts. If earbuds tend to fall out of your ears, the Beats Powerbeats Fit are worth considering now that they’re on sale as part of Amazon’s Big Spring Sale , which drops them to an all-time low of $169.99 ($30 off) at Amazon , Best Buy , and B&H Photo . Beats Powerbeats Fit Where to Buy: $199.99 $169.96 at Amazon $199.99 $169.99 at Best Buy $199.95 $169.95 at B&H Photo The Powerbeats Fit, which launched in September , offer similar functionality for iPhone users as AirPods (namely, easy connectivity and hands-free Siri support), but their built-in silicone fin and ear tips should ensure a snug fit that you won’t get with a traditional pair of Apple earbuds. Like several recent Beats models, the Powerbeats Fit work great with Android, too, and charge via USB-C. The Powerbeats Fit debuted after the Beats Fit Pro and stellar Powerbeats Pro 2 , yet some complaints we had with the first-gen model remain. For instance, the Fit use Apple’s H1 wireless chip, not its newer H2 chip, which offers capabilities like better noise cancellation, adaptive audio, and conversation awareness in headphones that have it (the aforementioned Pro 2 have it). Also, its charging case is still quite large — even if it is smaller than the case that came with the original — and it doesn’t support wireless charging, which is a standard feature we expect to see in wireless earbuds at this price point. Beats Powerbeats Pro 2 Where to Buy: $249 $199.95 at Walmart $249 $199.95 at Amazon $249.99 $199.99 at Best Buy Those disadvantages won’t bother everyone, though. But if they bother you, there are a couple of alternatives to consider. If you’re on Android (...
On 3/31/26, Liberty Broadband Corp's Series A Cumulative Redeemable Preferred Stock (Symbol: LBRDP) will trade ex-dividend, for its quarterly dividend of $0.4375, payable on 4/15/26. As a percentage of LBRDP's recent share price of $23.91, this dividend works out to approximate
On 3/31/26, Liberty Broadband Corp's Series A Cumulative Redeemable Preferred Stock (Symbol: LBRDP) will trade ex-dividend, for its quarterly dividend of $0.4375, payable on 4/15/26. As a percentage of LBRDP's recent share price of $23.91, this dividend works out to approximate
(RTTNews) - After a slightly sluggish start and a subsequent brief spell in positive territory, the Switzerland market very nearly slipped below the flat line around noon on Monday. However, it recovered swiftly and traded firm still the end of the session thanks to strong buying
(RTTNews) - After a slightly sluggish start and a subsequent brief spell in positive territory, the Switzerland market very nearly slipped below the flat line around noon on Monday. However, it recovered swiftly and traded firm still the end of the session thanks to strong buying
Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually in the coming years. In this environment, identifying growth companies with high insider ownership can be particularly appealing as it suggests management's confidence in their long-term potential amidst these fluctuating market con...
Over the last 7 days, the United States market has experienced a 1.9% drop, yet it remains up by 15% over the past year with earnings projected to grow by 15% annually in the coming years. In this environment, identifying growth companies with high insider ownership can be particularly appealing as it suggests management's confidence in their long-term potential amidst these fluctuating market conditions.
Choosing the right home for your retirement nest egg is important. And if you don't have an employer plan, you can open an IRA on your own. IRAs come in two main varieties -- traditional and Roth. And funding a traditional IRA may be tempting because you get a tax break on your contributions. With a Roth IRA , there's no immediate benefit. Image source: Getty Images. Continue reading
Choosing the right home for your retirement nest egg is important. And if you don't have an employer plan, you can open an IRA on your own. IRAs come in two main varieties -- traditional and Roth. And funding a traditional IRA may be tempting because you get a tax break on your contributions. With a Roth IRA , there's no immediate benefit. Image source: Getty Images. Continue reading
Citigroup Inc. is approaching other lenders to join a roughly $4.8 billion financing backing Ecolab Inc.’s purchase of CoolIT Systems Inc. , people with knowledge of the matter. The deal will likely involve selling investment-grade bonds, the people said. Ecolab, a St. Paul, Minnesota-based company that provides water and hygiene services to commercial and industrial businesses, announced earlier ...
Citigroup Inc. is approaching other lenders to join a roughly $4.8 billion financing backing Ecolab Inc.’s purchase of CoolIT Systems Inc. , people with knowledge of the matter. The deal will likely involve selling investment-grade bonds, the people said. Ecolab, a St. Paul, Minnesota-based company that provides water and hygiene services to commercial and industrial businesses, announced earlier this month its plan to buy CoolIT from funds managed by KKR & Co. for $4.75 billion in cash. CoolIT develops cooling technology for AI data centers. Citi declined to comment while Ecolab did not immediately respond to a comment request. Bond grader S&P Global Ratings , which rates Ecolab’s senior unsecured debt at A-, said the deal will push debt levels higher in the short term but that it will have little impact on credit metrics longer-term. Fitch last week affirmed its A- rating for the company’s senior-unsecured debt. The ratings firm said it expects Ecolab will be able to reduce gross leverage to around or below 2.5x within up to two years after the CoolIT acquisition. More M&A financings are expected to hit the high-grade bond market, including for Paramount Skydance Corp’s acquisition of Warner Bros . That deal includes about $40 billion of new debt split between high-grade and junk-rated bonds as well as loans.
Dern will play Miami Herald reporter Julie K Brown in first scripted take on the Epstein story, based on Brown’s book Laura Dern is taking on the Jeffrey Epstein investigation, in a new limited series executive produced by Adam McKay based on journalist Julie K Brown’s work busting open the story. Dern will play Brown, the Miami Herald investigative reporter on the late, disgraced financier’s tail...
Dern will play Miami Herald reporter Julie K Brown in first scripted take on the Epstein story, based on Brown’s book Laura Dern is taking on the Jeffrey Epstein investigation, in a new limited series executive produced by Adam McKay based on journalist Julie K Brown’s work busting open the story. Dern will play Brown, the Miami Herald investigative reporter on the late, disgraced financier’s tail when no one else was, for the first scripted take on the Epstein case. The screenplay will be based on Brown’s 2021 book Perversion of Injustice: The Jeffrey Epstein story. Sharon Hoffman, a writer on the 2020 limited series Mrs America, will write the project and serve as co-showrunner with Eileen Myers (The Night Agent, Masters of Sex). McKay, the writer-director of Don’t Look Up and executive producer on the HBO juggernaut Succession, among other credits, will serve as executive producer alongside Dern and Brown. Continue reading...
Svetlana Ritane/iStock via Getty Images DBV Technologies Overview DBV Technologies’ stock ( DBVT ) is up over 400% in the past year. Data by YCharts Almost exactly a year ago today, DBV announced that the FDA informed them that its VITESSE Phase 3 trial evaluating its Viaskin Peanut patch in 4 to 7-year-olds would, alone, be sufficient for a BLA. Months later, in December, DBV revealed VITESSE top...
Svetlana Ritane/iStock via Getty Images DBV Technologies Overview DBV Technologies’ stock ( DBVT ) is up over 400% in the past year. Data by YCharts Almost exactly a year ago today, DBV announced that the FDA informed them that its VITESSE Phase 3 trial evaluating its Viaskin Peanut patch in 4 to 7-year-olds would, alone, be sufficient for a BLA. Months later, in December, DBV revealed VITESSE topline results. 46.6% of children treated with the VIASKIN® Peanut patch met response criteria at 12 months, compared to 14.8% of children in the placebo arm. Its plan was to submit a BLA for 4 to 7 year-olds in the 1H 2026. Having covered Aimmune (later acquired by Nestle in 2020 for Palforzia, a peanut allergen oral immunotherapy powder) in the past, I have some familiarity with this market. Below, I make the case that DBVT’s ~$1B market capitalization merits caution ahead of what figures to be a challenging launch for Viaskin. A Shrinking Market Peanut allergy management primarily focuses on avoidance and the treatment of accidental exposures. Author's Compilation Over the past decade, there has been a shift to peanut allergy prevention. In 2015, the LEAP study proved that early introduction reduced allergy risk by >80%. And by 2021, guidelines around the world recommended early introduction for all infants. The 2025 iREACH trial showed that baseline adoption of these new recommendations was just ~10%-35%. Current data (conducted by CHOP and published in Pediatrics ) shows a 43% drop in overall peanut allergy incidence since the 2017 guidelines were implemented. The study found significant reductions in the prevalence of peanut IgE-mediated food allergy (from 0.79% to 0.45% of the study population) and any IgE-mediated food allergy (1.46% to 0.93% of the population) from the time before the guidelines to after the addendum guidelines were introduced. It has been almost a decade since the NIAID/NIH addendum. So, in just this short time, DBV’s target market has materially di...
May arabica coffee (KCK26 ) today is down -7.35 (-2.44%), and May ICE robusta coffee (RMK26 ) is down -159 (-4.43%). Coffee prices are sharply lower today, with arabica posting a 1-week low and robusta posting a 7.75-month low. The outlook for a record Brazilian coffee crop is weighing on...
May arabica coffee (KCK26 ) today is down -7.35 (-2.44%), and May ICE robusta coffee (RMK26 ) is down -159 (-4.43%). Coffee prices are sharply lower today, with arabica posting a 1-week low and robusta posting a 7.75-month low. The outlook for a record Brazilian coffee crop is weighing on...
May WTI crude oil (CLK26 ) today is up +3.05 (+3.06%), and May RBOB gasoline (RBK26 ) is up +0.0791 (+2.48%). Crude oil and gasoline prices are climbing today, with crude oil rallying to a 3-week high after President Trump threatened to escalate the Iran war if there is no...
May WTI crude oil (CLK26 ) today is up +3.05 (+3.06%), and May RBOB gasoline (RBK26 ) is up +0.0791 (+2.48%). Crude oil and gasoline prices are climbing today, with crude oil rallying to a 3-week high after President Trump threatened to escalate the Iran war if there is no...
Get a jump start on the US trading day with Dani Burger on "Bloomberg Open Interest." Brent crude races to a record monthly gain as US and Iran tensions escalate, lifting aluminum after Gulf smelter strikes. Wall Street is on edge with hedge funds pulling back, and Sysco seals a $29 billion mega-deal for Jetro. York Space CEO Dirk Wallinger joins us in the C-suite on the race to dominate space, De...
Get a jump start on the US trading day with Dani Burger on "Bloomberg Open Interest." Brent crude races to a record monthly gain as US and Iran tensions escalate, lifting aluminum after Gulf smelter strikes. Wall Street is on edge with hedge funds pulling back, and Sysco seals a $29 billion mega-deal for Jetro. York Space CEO Dirk Wallinger joins us in the C-suite on the race to dominate space, Democratic Strategist Adam Hodge joins us on rising geopolitical risk, and Ken Kencel, Churchhill Asset Managemetn President and CEO gives us his insight on mounting pressure across private markets. (Source: Bloomberg)
Adam Crystal, President, R&D of Tango Therapeutics (NASDAQ:TNGX) , reported the sale of 20,251 shares of common stock on March 5, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($15.00); post-transaction value based on March 5, 2026 market close price. * 1-year price change calculated using March 30, 2026 as the reference date. Continue reading
Adam Crystal, President, R&D of Tango Therapeutics (NASDAQ:TNGX) , reported the sale of 20,251 shares of common stock on March 5, 2026, according to a SEC Form 4 filing . Transaction value based on SEC Form 4 reported price ($15.00); post-transaction value based on March 5, 2026 market close price. * 1-year price change calculated using March 30, 2026 as the reference date. Continue reading